Clinical characteristics of patients
| Characteristics | (n=20) |
|---|---|
| Age, years and median (range) | 85.5 (71–96) |
| Gender (male/female) | 12/8 |
| Period from PEG to PEG-J, days, median (range) | 33 (14–280) |
| Use of semisolid feed before PEG-J, n (%) | 13 (65) |
| Comorbidities | |
| Stroke, n (%) | 15 (75) |
| Dementia, n (%) | 8 (40) |
| Respiratory disorders, n (%) | 12 (60) |
| Cardiovascular disorders, n (%) | 7 (35) |
| Diabetes mellitus, n (%) | 2 (10) |
| Pressure ulcers, n (%) | 4 (20) |
| Preoperative nutritional parameters | |
| Body mass index, kg/m2, mean (SD) | 17.5 (2.6) |
| Serum albumin, g/dL, mean (SD) | 2.8 (0.4) [3.0 (0.6)]* |
| Total lymphocyte count, /μL, mean (SD) | 1372 (514) [1294 (536)] |
| C reactive protein, mg/dL, mean (SD) | 3.2 (2.8) [2.6 (3.6)] |
| Blood urea nitrogen, mg/dL, mean (SD) | 23.0 (12.2) [23.1 (14.6)] |
Values in parentheses [ ] are pre-PEG values.
* p<0.05 vs pre-PEG value using the Wilcoxon signed-rank test.
PEG, percutaneous endoscopic transgastric; PEG-J, percutaneous endoscopic transgastric jejunostomy.